The compound pyrimidin-2-ylamino-1h-pyrazol is used as an LRRK2 inhibitor for the treatment of neurodegenerative disorders.

VN10059793BActive Publication Date: 2026-08-03DENALI THERAPEUTICS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: VN1202202950
Authority / Receiving Office: VN · VN
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2017-06-15
Publication Date: 2026-08-03
Estimated Expiration: 2037-06-15

Application Information

Patent Timeline

15 Jun 2017

Application

VN1202202950

03 Aug 2026

Publication

VN10059793B

Inventors: ESTRADA, Anthony A.; FENG, Jianwen A.

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention generally relates to LRRK2 inhibitors, or pharmaceutical salts, deuterized analogues, prodrugs, adjuvants, stereoisomers, or mixtures of stereoisomers thereof, and methods for preparing them.

Need to check novelty before this filing date? Find Prior Art